Clinical trial NCT02489877 - References

Multiple Sclerosis — Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus

Citation(s)

•   't Hart BA, van Meurs M, Brok HP, Massacesi L, Bauer J, Boon L, Bontrop RE, Laman JD
  A new primate model for multiple sclerosis in the common marmoset. Immunol Today. 2000 Jun;21(6):290-7.
•   Bernard CC, de Rosbo NK
  Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol (Napoli). 1991 Apr;13(2):171-8. Review.
•   Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J
  Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med (Berl). 1997 Feb;75(2):77-88. Review.
•   Blond JL, Besème F, Duret L, Bouton O, Bedin F, Perron H, Mandrand B, Mallet F
  Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol. 1999 Feb;73(2):1175-85.
•   Christensen T, Tönjes RR, zur Megede J, Boller K, Møller-Larsen A
  Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis. AIDS Res Hum Retroviruses. 1999 Feb
•   Dolei A, Serra C, Mameli G, Pugliatti M, Sechi G, Cirotto MC, Rosati G, Sotgiu S
  Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology. 2002 Feb 12;58(3):471-3.
•   Egg R, Reindl M, Deisenhammer F, Linington C, Berger T
  Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult Scler. 2001 Oct;7(5):285-9.
•   Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H
  Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet. 1998 Jan 3;351(9095):33.
•   Genain CP, Cannella B, Hauser SL, Raine CS
  Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med. 1999 Feb;5(2):170-5.
•   Genain CP, Hauser SL
  Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med (Berl). 1997 Mar;75(3):187-97. Review.
•   Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P
  T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res. 2001 Feb 1;63(3):290-302.
•   Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, Ott C, Rajoharison A, Garcia E, Mallet F, Mandrand B, Perron H
  Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virolo
•   Lassmann H, Brück W, Lucchinetti C
  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med. 2001 Mar;7(3):115-21. Review.
•   Mameli G, Poddighe L, Astone V, Delogu G, Arru G, Sotgiu S, Serra C, Dolei A
  Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods. 2009 Oct;161(1):98-106.
•   Martin R, McFarland HF
  Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci. 1995;32(2):121-82. Review.
•   Owens GP, Gilden D, Burgoon MP, Yu X, Bennett JL
  Viruses and multiple sclerosis. Neuroscientist. 2011 Dec;17(6):659-76. doi: 10.1177/1073858411386615. Review.
•   Perron H, Firouzi R, Tuke P, Garson JA, Michel M, Beseme F, Bedin F, Mallet F, Marcel E, Seigneurin JM, Mandrand B
  Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurol Scand Suppl. 1997;169:22-3
•   Perron H, Gratacap B, Lalande B, Genoulaz O, Laurent A, Geny C, Mallaret M, Innocenti P, Schuller E, Stoebner P, et al
  In vitro transmission and antigenicity of a retrovirus isolated from a multiple sclerosis patient. Res Virol. 1992 Sep-Oct;143(5):337-5
•   Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M
  Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry. 2008 Dec 15;64(12):1019-23. doi: 10.1016/j.biopsych.2008.06.028. Epub 2008
•   Sellebjerg F, Christiansen M, Garred P
  MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis. Mult Scler. 1998 Jun;4(3):127-31.
•   Serra C, Sotgiu S, Mameli G, Pugliatti M, Rosati G, Dolei A
  Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci. 2001 Apr;22(2):171-3.
•   Sotgiu S, Arru G, Mameli G, Serra C, Pugliatti M, Rosati G, Dolei A
  Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Mult Scler. 2006 Dec;12(6):698-703.
•   Sotgiu S, Mameli G, Serra C, Zarbo IR, Arru G, Dolei A
  Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler. 2010 Oct;16(10):1248-51. doi: 10.1177/1352458510376956. Epub 2010 Aug 4.
•   Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, Arru G, Dolei A
  Multiple sclerosis-associated retrovirus and MS prognosis: an observational study. Neurology. 2002 Oct 8;59(7):1071-3.
•   Steinman L
  Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 1996 May 3;85(3):299-302. Review.
•   Sun JB, Olsson T, Wang WZ, Xiao BG, Kostulas V, Fredrikson S, Ekre HP, Link H
  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol. 1991 Jun;21(6):1461-8.

Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus in Peripheral Blood of Patients

Details for clinical trial NCT02489877